The future of asthma research and development: a roadmap from the European Asthma Research and Innovation Partnership (EARIP). Issue 5 (2nd May 2017)

• Record Type: Journal Article
• Authors: Masefield, Sarah; Edwards, Jessica; Hansen, Kjeld; Hamerlijnck, Dominique; Lisspers, Karin; van der Schee, Marc; Silva, Liliana; Matthews, John; Gaga, Mina; Adcock, Ian; Holgate, Stephen; Walker, Samantha; Powell, Pippa
• Is Part Of: European respiratory journal. Volume 49:Issue 5(2017)
• Publication Date: 2017-05-02
• Subjects: Respiratory organs -- Diseases -- Periodicals; Respiration -- Periodicals; 616.2
• DOI: 10.1183/13993003.02295-2016
• Languages: English
• ISSNs: 0903-1936

Abstract

Asthma is highly prevalent and associated with high morbidity and mortality. It affects 30–50 million people in Europe, often starting in infancy and persisting throughout life. Asthma is a major global health challenge, affecting more than 300 million people worldwide and at least 10% of all Europeans [1]. People with asthma live at risk of life-threatening asthma attacks, leading to over 500 000 hospitalisations each year. Approximately 5–10% of asthma cases are so severe that current treatments do not work. Asthma outcomes will be transformed if the priorities in the EARIP research roadmap are addressed http://ow.ly/9maP307TVNk